AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Abiraterone acetate'
:
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Publication Year: 2008
DOI: https://doi.org/10.1200/jco.2007.15.9749
Abstract:
Add to Library
Authors:
Gerhardt Attard
Alison Reid
Timothy A. Yap
Florence I. Raynaud
Mitch Dowsett
S. Settatree
Mary Barrett
Christopher Parker
Vanessa Martins
Elizabeth Folkerd
J. W. Clark
Colin S. Cooper
Stan B. Kaye
David P. Dearnaley
Gloria Lee
Johann S. de Bono
Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
Publication Year: 2009
DOI: https://doi.org/10.1200/jco.2008.20.0642
Abstract:
Add to Library
Authors:
Gerhardt Attard
Alison Reid
Roger A’Hern
Christopher Parker
Nikhil Babu Oommen
Elizabeth Folkerd
Christina Messiou
L. Rhoda Molife
Gal Maier
Emilda Thompson
David Olmos
R. Sinha
Gloria Lee
Mitch Dowsett
Stan B. Kaye
David P. Dearnaley
Thian Kheoh
Arturo Molina
Johann S. de Bono
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Publication Year: 2012
DOI: https://doi.org/10.1016/s1470-2045(12)70379-0
Abstract:
Add to Library
Authors:
Karim Fizazi
Howard I. Scher
Arturo Molina
Christopher J. Logothetis
Kim N.
Robert J. Jones
John Staffurth
Scott North
Nicholas J. Vogelzang
Fred Saad
Paul N. Mainwaring
Stephen Harland
Oscar B. Goodman
Cora N. Sternberg
Jin Hui Li
Thian Kheoh
Christopher M. Haqq
Johann S. de Bono
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
Publication Year: 2004
DOI: https://doi.org/10.1038/sj.bjc.6601879
Abstract:
Add to Library
Authors:
Anne O’Donnell
Ian Judson
Mitch Dowsett
Florence I. Raynaud
David P. Dearnaley
M. Mason
S.J. Harland
Alissa K. Robbins
Gavin Halbert
Bernard Nutley
Michael Jarman
Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate
Publication Year: 2010
DOI: https://doi.org/10.1200/jco.2009.24.6819
Abstract:
Add to Library
Authors:
Alison Reid
Gerhardt Attard
Daniel C. Danila
Nikhil Babu Oommen
David Olmos
Peter C.C. Fong
L. Rhoda Molife
Joanne Hunt
Christina Messiou
Christopher Parker
David P. Dearnaley
Joost F. Swennenhuis
Leon W.M.M. Terstappen
Gloria Lee
Thian Kheoh
Arturo Molina
Charles J. Ryan
Eric J. Small
Howard I. Scher
Johann S. de Bono
Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
Publication Year: 2010
DOI: https://doi.org/10.1200/jco.2009.25.9259
Abstract:
Add to Library
Authors:
Daniel C. Danila
Michael J. Morris
Johann S. de Bono
Charles J. Ryan
Samuel R. Denmeade
Matthew R. Smith
Mary-Ellen Taplin
Glenn J. Bubley
Thian Kheoh
Christopher M. Haqq
Arturo Molina
Aseem Anand
Michael Koscuiszka
Steven M. Larson
Lawrence H. Schwartz
Martin Fleisher
Howard I. Scher
Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy
Publication Year: 2010
DOI: https://doi.org/10.1200/jco.2009.24.1281
Abstract:
Add to Library
Authors:
Charles J. Ryan
Matthew R. Smith
Lawrence Fong
Jonathan E. Rosenberg
Philip W. Kantoff
Florence I. Raynaud
Vanessa Martins
Gloria Lee
Thian Kheoh
Jennifer Kim
Arturo Molina
Eric J. Small
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Publication Year: 2015
DOI: https://doi.org/10.1016/s1470-2045(14)71205-7
Abstract:
Add to Library
Authors:
Charles J. Ryan
Matthew R. Smith
Karim Fizazi
Fred Saad
Peter F.A. Mulders
Cora N. Sternberg
Kurt Miller
Christopher J. Logothetis
Neal D. Shore
Eric J. Small
Joan Carles
Thomas W. Flaig
Mary-Ellen Taplin
Celestia S. Higano
Paul de Souza
Johann S. de Bono
Thomas W. Griffin
Peter De Porre
Margaret K. Yu
Youn C. Park
Jinhui Li
Thian Kheoh
Vahid Naini
Arturo Molina
Dana E. Rathkopf
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Publication Year: 2011
DOI: https://doi.org/10.1056/nejmoa1014618
Abstract:
Add to Library
Authors:
Johann S. de Bono
Christopher J. Logothetis
Arturo Molina
Karim Fizazi
Scott North
Luis Chu
Kim N.
Robert J. Jones
Oscar B. Goodman
Fred Saad
John Staffurth
Paul N. Mainwaring
Stephen Harland
Thomas W. Flaig
Thomas E. Hutson
Tina Cheng
Helen Patterson
John D. Hainsworth
Charles J. Ryan
Cora N. Sternberg
Susan Ellard
Aude Fléchon
Mansoor N. Saleh
Mark C. Scholz
Eleni Efstathiou
Andrea Zivi
Diletta Bianchini
Yohann Loriot
Nicole Chieffo
Thian Kheoh
Christopher M. Haqq
Howard I. Scher
Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
Publication Year: 2011
DOI: https://doi.org/10.1200/jco.2010.33.7675
Abstract:
Add to Library
Authors:
Eleni Efstathiou
Mark Titus
Dimitra Tsavachidou
Vassiliki Tzelepi
Sijin Wen
Anh Hoang
Arturo Molina
Nicole Chieffo
Lisa A. Smith
Μαρία Κάρλου
Patricia Troncoso
Christopher J. Logothetis
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
Publication Year: 2013
DOI: https://doi.org/10.1093/annonc/mdt138
Abstract:
Add to Library
Authors:
Krista Noonan
Scott North
Rhonda L. Bitting
Andrew J. Armstrong
Susan Ellard
K.N. Chi
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Publication Year: 2014
DOI: https://doi.org/10.1016/j.eururo.2014.10.027
Abstract:
Add to Library
Authors:
Roberta Ferraldeschi
Daniel Nava Rodrigues
Ruth Riisnaes
Susana Miranda
Ines Figueiredo
Pasquale Rescigno
Praful Ravi
Carmel Pezaro
Aurelius Omlin
David Lorente
Zafeiris Zafeiriou
Joaquı́n Mateo
Amelia Altavilla
Spyridon Sideris
Diletta Bianchini
Emily Grist
Khin Thway
Raquel Pérez-López
Nina Tunariu
Chris Parker
David P. Dearnaley
Alison Reid
Gerhardt Attard
Johann S. de Bono
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Publication Year: 2019
DOI: https://doi.org/10.1016/s1470-2045(19)30082-8
Abstract:
Add to Library
Authors:
Karim Fizazi
NamPhuong Tran
Luis Fein
Nobuaki Matsubara
A. Rodrı́guez-Antolı́n
B. Yа. Alekseev
Mustafa Özgüroğlu
Dingwei Ye
Susan Feyerabend
Andrew Protheroe
Giri Sulur
Yesenia Luna
Susan Li
Suneel Mundle
Kim N.
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Publication Year: 2013
DOI: https://doi.org/10.1093/annonc/mdt136
Abstract:
Add to Library
Authors:
Yohann Loriot
Diletta Bianchini
E. Ileana
Shahneen Sandhu
Anna Patrikidou
Carmel Pezaro
Laurence Albigès
Gerhardt Attard
Karim Fizazi
Johann S. de Bono
Christophe Massard
Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
Publication Year: 2011
DOI: https://doi.org/10.1158/1078-0432.ccr-11-0815
Abstract:
Add to Library
Authors:
Charles J. Ryan
Shreya Shah
Eleni Efstathiou
Matthew R. Smith
Mary-Ellen Taplin
Glenn J. Bubley
Christopher J. Logothetis
Thian Kheoh
Christine Kilian
Christopher M. Haqq
Arturo Molina
Eric J. Small
Found 8179 results in 0.163 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"